Loading...
XSHE
300813
Market cap381mUSD
Jul 09, Last price  
21.37CNY
1D
1.57%
1Q
-26.69%
IPO
52.96%
Name

Zhejiang Tailin Bioengineering Co Ltd

Chart & Performance

D1W1MN
XSHE:300813 chart
P/E
157.11
P/S
7.74
EPS
0.14
Div Yield, %
0.94%
Shrs. gr., 5y
2.21%
Rev. gr., 5y
3.38%
Revenues
334m
-4.18%
94,463,28659,499,81482,332,546111,760,609142,018,122159,097,740180,928,327200,237,531283,248,491283,248,490373,878,114373,878,113269,856,059348,998,252334,413,918
Net income
16m
+26.32%
21,456,57610,122,09115,372,39629,016,36244,987,88048,214,59034,406,39648,385,61863,529,85163,529,85179,686,20279,686,20619,668,95213,050,67216,485,445
CFO
57m
+131.61%
11,512,35917,508,48524,540,41831,563,27023,043,84637,326,17329,039,126106,282,84535,961,76989,385,6191,931,88424,656,61457,106,221
Dividend
Sep 25, 20250.1 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhejiang Tailin BioEngineering Co.,Ltd offers life science system solutions in China. The company offers cell and gene therapy solutions, including biosafety ferret isolators, sterile pig preparation solutions, aseptic filling workstation, cell preparation workstation, and robotic packaging workstations; drug development and sterile production solutions, comprising sterile packaging, highly active drug development/production, aseptic material transfer, packaging and test equipment, automated production solutions, sterility tests, and sterile connectors; microbiological detection systems; sterility testing systems; biodecontamination and infection control solutions; analytical instruments; quality control solutions, and laboratory animals/scientific research products, as well as active microbial products, and membrane materials. Its products are used in bio-pharmaceuticals, biosafety, disease control, food safety, and other industries. Zhejiang Tailin BioEngineering Co.,Ltd was formerly known as Hangzhou Tailin Biotechnology Equipment Co., Ltd. and changed its name to Zhejiang Tailin BioEngineering Co.,Ltd in April 2015. The company was founded in 1993 and is based in Hangzhou, China.
IPO date
Jan 14, 2020
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT